Son una "salida fcil" para quienes no quieren hacer dieta
News provided by BD (Becton, Dickinson and Company) Jul 29, 2026, 06:54 ET Collaboration pairs leadership in pharmaceuticals and advanced drug delivery technology to support a consistent, reliable treatment experience for metabolic disease patients
I am doing so much better now
On average, those in the semaglutide group lost about 5% of their body weight during the trial
And I usually help to educate patients to minimize these side effects by eating smaller, more frequent meals, eating slowly, staying hydrated, watching high fat or high fiber meals, especially right after you do your injection